Brian W Metcalf Net Worth & Insider Trades
Brian W Metcalf - Chief Drug Discovery Scientist, Incyte Corp
What is Brian W Metcalf's Net Worth?
The current estimated net worth of Incyte Corp's Chief Drug Discovery Scientist, Brian W Metcalf, is estimated to be about $7.92M . Brian W Metcalf owns about 66,504 units of Incyte Corp common stock. In the last 7 years at Incyte Corp, Brian W Metcalf has sold an estimated value of $5.45M worth.
What is Brian W Metcalf's Past Insider Trading?
Brian W Metcalf's largest purchase order was 210,000 units , worth over $2.07M on March 18, 2011. Brian W Metcalf's largest sale order was 210,000 units , worth over $3M on March 18, 2011. In total, Brian W Metcalf has made about 12 transactions over 7 years of their time at Incyte Corp. Brian W Metcalf usually trades in January and February, with the busiest year in 2011. The most recent transaction was a sale order of 100,000 units , worth over $1.74M on April 13, 2011.
Brian W Metcalf
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Brian W Metcalf's' Mailing Address?
- Mailing address is 3160 Porter Drive Polo Alto CA 94304 CA
Incyte Corp Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Hervé Hoppenot | 2020 | $1,094,731 | - | $8,317,223 | $5,515,024 | $1,403,468 | $47,746 | $16,378,192 |
| Hervé Hoppenot | 2019 | $1,044,376 | - | $6,740,953 | $5,937,070 | $1,382,183 | $46,656 | $15,151,238 |
| Hervé Hoppenot | 2018 | $995,575 | - | $1,733,822 | $5,564,508 | $807,769 | $212,515 | $9,314,189 |
| Christiana Stamoulis | 2020 | $585,468 | - | $1,743,359 | $1,421,498 | $375,321 | $28,604 | $4,154,250 |
| Christiana Stamoulis | 2019 | $497,096 | $280,000 | $824,960 | $2,474,685 | $369,600 | $49,327 | $4,495,668 |
| Barry P. Flannelly | 2020 | $480,542 | - | $2,342,694 | $940,557 | $308,057 | $45,034 | $4,116,884 |
| Barry P. Flannelly | 2019 | $458,438 | - | $1,149,505 | $3,490,293 | $303,361 | $41,345 | $5,442,942 |
| Steven H. Stein | 2020 | $576,321 | - | $1,418,393 | $940,557 | $369,457 | $22,022 | $3,326,750 |
| Steven H. Stein | 2019 | $549,812 | - | $4,868,505 | $1,235,249 | $363,825 | $24,093 | $7,041,484 |
| Steven H. Stein | 2018 | $522,123 | - | $3,733,824 | $2,119,070 | $212,625 | $23,874 | $6,611,516 |
| Vijay Iyengar | 2020 | $552,278 | - | $1,418,393 | $940,557 | $353,299 | $40,323 | $3,304,850 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/879169/000104746921000962/a2243134zdef14a.htm
What are Incyte Corp's Past Insider Trades?
Incyte Corp's most recent insider trade came on July 26, 2022 by Thomas Tray who sold 1,564 units worth $130.02K . In the last 19 years, insiders at Incyte Corp have sold an estimated value of $630.74M and bought an estimated value of $874.58M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Julian Baker, Director, Felix Baker, Director, and Paula Swain, EVP .
INCYTE CORP Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||